BACKGROUND
Discontinuation of oral anticoagulant (OAC) in patients without recurrent atrial arrhythmia after ablation for atrial fibrillation (AF) has been demonstrated to reduce composite outcomes of stroke, systemic embolism, and major bleeding compared with continued OAC.
OBJECTIVE
This study aimed to evaluate the...
Young-Shin Lee, J. Uhm, Junbeom Park et al.· Heart Rhythm· 0 citations
BACKGROUND
Clinical outcomes of driver-targeted ablation in persistent atrial fibrillation (AF) have been inconsistent, underscoring the need for virtual heart-based approaches to characterize AF driver dynamics and guide ablation strategies. We used virtual heart models from a large persistent AF cohort to define elec...
Taehyun Hwang, O. Kwon, Jaeyeon Huh et al.· Circulation: Arrhythmia and...· 0 citations
ABSTRACT The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifest...
B. Joung, R. Krittayaphong, Yu-Tao Guo et al.· Journal of Arrhythmia· 0 citations
ABSTRACT The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifest...
Tze-Fan Chao, Gregory Y. H. Lip, Yi-Hsin Chan et al.· Journal of Arrhythmia· 0 citations
Integrating genetic risk and AI‐ECG–derived features enhances AF prediction beyond an established clinical model, supporting the use of combined digital and genetic biomarkers for risk stratification.
Pil-Sung Yang, Hanjin Park, O. Kwon et al.· Journal of Arrhythmia· 0 citations
Among patients with atrial fibrillation at intermediate risk for stroke, DOAC therapy led to a lower risk of stroke, systemic embolism, major bleeding, or death from cardiovascular causes at 24 months than no anticoagulation.
Daehoon Kim, Young-soo Lee, J. Shim et al.· New England Journal of Medic...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.